Application of propranolol in the management of aggression in schizophrenic patients Academic Article uri icon


  • One of the major problems which continues to plague our understanding of schizophrenia is that of homogeneity. Schizophrenia is not a homogenous disease. Limited success at the identification of subtypes of schizophrenia have arisen from research using computerized tomography, magnetic resonance imaging, electrophysiological and neuropsychological measures. Homogenization of patient populations through the study of response to specific medications in combination with family history of schizophrenia has not been widely studied. This type of research may serve to homogenize patients by way of biological markers based on the sites of action of medications and familial predisposition. A group of 34 patients diagnosed with schizophrenia (mean age = 32 years) having received halo- peridol in their participation in various double blind clinical trials are currently being studied to determine if a positive family history of psychiatric …

publication date

  • January 1, 1996